SEC 13F Intelligence

Orbimed Advisors LLC / TRVI

Orbimed Advisors LLC’s Trevi Therapeutics Inc Position

Does Orbimed Advisors LLC own Trevi Therapeutics Inc (TRVI)? Yes — 2.45M shares worth $29M (+0.58% of its 13F portfolio) as of Q1 2026, down from 3.19M shares the prior filed quarter.

Position Value
$29M
Q1 2026
Shares
2.45M
% of Portfolio
+0.58%
Quarters Held
5
currently held

Position History TRVI

Reported value by quarter
Q1 ’25: $7MQ1 ’25Q2 ’25: $18MQ2 ’25Q3 ’25: $30MQ3 ’25Q4 ’25: $40MQ4 ’25Q1 ’26: $29MQ1 ’26filingsflow.com
QuarterSharesValue% of Portfolio
Q1 20262.45M$29M+0.58%
Q4 20253.19M$40M+0.82%
Q3 20253.31M$30M+0.71%
Q2 20253.31M$18M+0.45%
Q1 20251.12M$7M+0.17%

Common-stock position only; options are excluded. Quarters where the fund filed no 13F or reported no position are absent. See Orbimed Advisors LLC’s full portfolio or all institutional holders of TRVI.